BIOMAT Database Logo BIOMAT Database Logo

[Pharmacological properties of alpha-phenyl-alpha-(2-piperdino-ethyl)-beta-ethyl-butyronitrile. I]. 1958

H KASPAREK, and K PFROEPFFER

UI MeSH Term Description Entries
D009125 Muscle Relaxants, Central A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) Centrally Acting Muscle Relaxants,Central Muscle Relaxants,Relaxants, Central Muscle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H KASPAREK, and K PFROEPFFER
[Pharmacological properties of new derivatives of 1-(2'-morpholine-ethyl)-4-phenyl-4-acylpiperidine].
January 1970, Acta poloniae pharmaceutica,
H KASPAREK, and K PFROEPFFER
[Various pharmacological aspects of 2-phenyl-2-ethyl-4-thiocyano-glutarimide].
February 1970, Bollettino chimico farmaceutico,
H KASPAREK, and K PFROEPFFER
Some pharmacological properties of phenyl alpha-naphthyl ketimine.
June 1955, Journal of the American Pharmaceutical Association. American Pharmaceutical Association,
H KASPAREK, and K PFROEPFFER
[Synthesis of some derivatives of 2-ethyl-3-phenyl-3-aminopropanol and their pharmacological properties].
October 1959, Il Farmaco; edizione scientifica,
H KASPAREK, and K PFROEPFFER
[Studies on beta-phenyl-ethyl-amine derivatives; 2-amino-phenyl-alkanes].
January 1952, Acta poloniae pharmaceutica,
H KASPAREK, and K PFROEPFFER
Resolution and pharmacological properties of the enantiomers of the potent alpha-adrenoceptor antagonist 1-[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxy-phenyl)piperazine.
May 1988, Arzneimittel-Forschung,
H KASPAREK, and K PFROEPFFER
Stereoselective synthesis of 2-S-ethyl(phenyl)-2-thio-beta-glucopyranosides via 1,2-migration and concurrent glycosidation of ethyl(phenyl) 2,3-orthoester-1-thio-alpha-mannopyranosides.
July 2001, Carbohydrate research,
H KASPAREK, and K PFROEPFFER
[Pharmacological activity of beta-lactams. II. Systemic effects of 3-methyl-3-phenyl-2-azetidinone and of 3-ethyl-3-phenyl-2-azetidinone].
January 1959, Il Farmaco; edizione scientifica,
H KASPAREK, and K PFROEPFFER
(S,2S,3R)-2-(2-Methyl-propane-2-sulfin-amido)-3-phenyl-butyronitrile.
October 2009, Acta crystallographica. Section E, Structure reports online,
H KASPAREK, and K PFROEPFFER
(S,2S,3S)-2-(2-Methyl-propan-2-sulfin-amido)-3-phenyl-butyronitrile.
October 2009, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!